All-Oral Therapy Promising in Higher-Risk MDS, CMML
(MedPage Today) -- An all-oral combination therapy appeared to show promising activity for patients with higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), with acceptable safety, according to results from a... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 5, 2024 Category: Hematology Source Type: news
Akel Homes Demonstrates Enthusiastic Support as Silver Benefactor for the 2024 LLS Black Tie Gala, Eager to Contribute to Life-Saving Cancer Research
Akel Homes proudly announces its support to the Leukemia & Lymphoma Society (LLS) as a Silver Benefactor sponsor of this year's Dare to Disco Black Tie Gala hosted at The Breakers, Palm Beach on January 24th. PALM BEACH, Fla., Feb. 2, 2024 /PRNewswire-PRWeb/ -- The 2024 Dare to Disco Gala... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 2, 2024 Category: Pharmaceuticals Tags: SVY NPT Source Type: news
Camp Lejeune Water Contamination Tied to a Range of Cancers
NEW YORK — Military personnel stationed at Camp Lejeune from 1975 to 1985 had at least a 20% higher risk for a number of cancers than those stationed elsewhere, federal health officials said Wednesday in a long-awaited study about the North Carolina base’s contaminated drinking water.
Federal health officials called the research one the largest ever done in the United States to assess cancer risk by comparing a group who live and worked in a polluted environment to a similar group that did not.
[time-brightcove not-tgx=”true”]
The study found military personnel stationed at U.S. Marine Corps ...
Source: TIME: Health - February 1, 2024 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized healthscienceclimate wire Source Type: news
Drug Trials Snapshots: REZLIDHIA
REZLIDHIA is a prescription medicine used to treat adults with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) mutation when the disease has come back (relapsed) or has not improved after one or more treatments (refractory). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 30, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Fight Your Blood Cancer: Early CAR NK Therapy Clinical Results
A novel cancer treatment using natural killer cells produces encouraging results in people with certain leukemias and lymphomas. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 29, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
When a Revolutionary Cancer Treatment Causes Cancer
(MedPage Today) -- My patient was young, in his thirties, and had a terrible leukemia that refused to be vanquished with multiple rounds of chemotherapy. Many of my adult patients, at the time of their diagnosis, tell me they are so happy they... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 27, 2024 Category: American Health Source Type: news
Cat with leukemia adopted by teenager who beat disease as a child
A cat has found the perfect forever home with a Tampa Bay family, thanks to a bond that goes beyond the ordinary. Tonka is 1-year-old and has Feline Leukemia Virus, a common and potentially fatal infectious disease that affects cats. FeLV can lead to various health issues, including anemia,…#tampabay #tonka #felineleukemiavirus #hstb #felv #reganblessinger #florida #felvp27 (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2024 Category: Consumer Health News Source Type: news
Risk for Cancer Increased for Relatives of Patients With Leukemia
THURSDAY, Jan. 18, 2024 -- Relatives of patients with myelodysplastic neoplasia (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) have an increased risk for cancer, according to a study published in the February issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 18, 2024 Category: Pharmaceuticals Source Type: news
A life-saving transplant awaits Arthur Yu — if the U.S. government lets his donor into the country
Arthur Yu needs a stem cell transplant if he's going to beat leukemia. But the government is blocking his Filipino cousin from visiting to make the donation. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - January 18, 2024 Category: Science Authors: Nathan Solis Source Type: news
Molecular & #039;super-glue & #039; shows promise of cancer drug discovery platform
Today, St. Jude Children's Research Hospital scientists published their work on SJ3149, a compound with broad activity against many cancer types, particularly acute myeloid leukemia (AML). SJ3149 sticks to the cancer-related protein casein kinase 1 alpha (CK1α), leading to its destruction. The findings were reported in Nature Communications. (Source: World Pharma News)
Source: World Pharma News - January 16, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
An Uber and Lyft driver took 2 years off to recover from leukemia. He says the pay now isn't enough to get by anymore
has driven for Uber for 11 years. Carlina Teteris Richard, a driver who recently beat leukemia, is considering dropping gig driving after 11 years. He said his earnings are unsustainable and are much less than what he made prior to his diagnosis. He was out of work for two years, though he's…#carlinateteris #richardh #phoenix #uber #screenshots (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2024 Category: Consumer Health News Source Type: news
What Prompts a Post-Childhood'Survival Cliff' in ALL? What Prompts a Post-Childhood'Survival Cliff' in ALL?
Experts explore why children with acute lymphoblastic leukemia fare well with current treatment options, while adolescents and younger adults still face high mortality rates.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 10, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
First ALL Treatment Guidance for Young Patients in the Works First ALL Treatment Guidance for Young Patients in the Works
: The American Society of Hematology is developing the first clinical practice guidelines for treating acute lymphocytic leukemia in adolescents and young adults.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 9, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
How one Atlanta man beat leukemia after a life-saving transplant
In late 2009, metro Atlanta resident Jermaine Reid was participating in a basketball game at his son ’s school when he realized he was having difficulty catching his breath.
He found himself gasping for air, the passages in his nose restricted with blood clots, as he suffered intense fatigue and an overwhelming headache.
He was only 38 at the time and although he had been off the court for some years, he knew that something serious was afflicting him.
After bloodwork and further examination at… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 1, 2024 Category: Pharmaceuticals Authors: Northside Hospital Source Type: news
Advances in Acute Lymphoblastic Leukemia From ASH 2023 Advances in Acute Lymphoblastic Leukemia From ASH 2023
Chemotherapy-free regimens in Philadelphia chromosome –positive acute lymphoblastic leukemia and optimization of combination therapies are among advances from ASH 2023 chosen by Dr Hagop Kantarjian.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news
